argenx Reports Third Quarter 2024 Financial Results and Provides Business Update
CIDP global expansion on track, with decisions on approval under review in Japan, Europe, China, and Canada Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology…